Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Aeterna Zentaris Inc will announce the topline results of the ZoptEC Phase clinical study of Zoptrex zoptarelin doxorubicin in women with locally advanced recurrent or metastatic endometrial cancer prior to the commencement of trading on Monday May...
Lonza is hosting a free minute webinar on May emphasizing the importance of data integrity for endotoxin testing With data integrity being a critical area for the endotoxintesting community Robert Porzio Product Manager for Endotoxin Detection at L...
Takeda Pharmaceutical Company Limited and Harrington Discovery Institute at University Hospitals in Cleveland Ohio have announced a multiyear collaboration to accelerate breakthrough therapeutic discoveries in rare diseasesA first of a kind partn...
PIQUR Therapeutics AG a Swiss clinicalstage pharmaceutical company announced today that the European Medicines Agency EMA has granted orphan drug designation to PIQURs lead compound PQR for the treatment of patients with diffuse large Bcell lymphoma...
Dr Reddys Laboratories Ltd announced today that it has launched Ezetimibe and Simvastatin Tablets mg mg mg mg mg mg and mg mg a therapeutic equivalent generic version of Vytorin Ezetimibe and Simvastatin Tablets in the United States market approv...
Flex Pharma Inc focused on developing treatments for cramps and spasms associated with the severe neurological diseases of amyotrophic lateral sclerosis ALS multiple sclerosis MS and peripheral neuropathies such as CharcotMarieTooth CMT today announc...
Impax Laboratories Inc a specialty pharmaceutical company today announced it has received final US Food and Drug Administration FDA approval for a generic version of Vytorin ezetimibesimvastatin tablets and mg and immediately initiated commercial...
CPhI Japan organised by UBM EMEA and UBM Asia returned to Tokyo for its th edition April st with the release of new research into the Japanese pharmaceutical market Over domestic and international companies attending the event were surveyed to pr...
Girish Malhotra President of EPCOT International and CPhI Worldwide Annual Industry Report member discusses the necessity of time reduction for ANDA approvals arguing that if the current approval time can be reduced from ten months to three months dr...
Aquinnah Pharmaceuticals a privately held biotechnology company focused on RNA binding proteins for neurodegenerative disease announced today that two additional pharmaceutical companies Pfizer Inc NYSE PFE and AbbVie Inc NYSE ABBV have invested in A...
